Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Rhea-AI Summary

Haemonetics (NYSE: HAE) has announced its participation in the upcoming Raymond James 46th Annual Institutional Investors Conference. Chris Simon, President and CEO, will engage in a fireside chat with investors on Tuesday, March 4, 2025, at 2:50 p.m. ET.

The event will be accessible to the public through a live webcast on Haemonetics' Investor Relations website and via a dedicated link. Following the presentation, a replay will be made available approximately 12 hours after the event and will remain accessible for 90 days through the company's Investor Relations website.

BOSTON, Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj131/hae/1437678. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com    

David Trenk, Manager-Investor Relations      
(203) 733-4987
david.trenk@haemonetics.com

Media Contact:
Josh Gitelson, Sr. Director-Global Communications      
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference-302382632.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics (HAE) presenting at the Raymond James Conference 2025?

Haemonetics (HAE) will present at the Raymond James Conference on Tuesday, March 4, 2025, at 2:50 p.m. ET.

How can investors watch Haemonetics' (HAE) Raymond James Conference presentation?

Investors can watch the presentation through a live webcast on Haemonetics' Investor Relations website or via the provided link: https://wsw.com/webcast/rj131/hae/1437678.

How long will the HAE Raymond James Conference webcast replay be available?

The webcast replay will be available for 90 days on Haemonetics' Investor Relations website, accessible starting 12 hours after the event.

Who is representing Haemonetics (HAE) at the Raymond James 2025 Conference?

Chris Simon, President and CEO of Haemonetics, will represent the company in a fireside chat with investors.